STAA - Staar Surgical sees FY26 sales $500M-$550M operating margin of 12%-16%
2023-09-14 14:20:57 ET
More on STAAR Surgical
- Seeking Alpha’s Quant Rating on STAAR Surgical
- Historical earnings data for STAAR Surgical
- Financial information for STAAR Surgical
- STAAR Surgical Company: The Stock Is Still An Eyesore
- STAAR Surgical: Economic Realities Beginning To Surface, Reiterate Hold
- STAAR Surgical Company ( STAA ) Q2 2023 Earnings Call Transcript
- STAAR Surgical gains after shareholder buys additional stake worth $7.87M
- Dolby Laboratories set to join S&P midcap 400; Staar Surgical to join S&P smallcap 600
- Canaccord cuts STAAR to hold, citing US adoption challenges for EVO lenses
- STAAR Surgical misses Q2 top and bottom line estimates; updates FY23 outlook
For further details see:
Staar Surgical sees FY26 sales $500M-$550M, operating margin of 12%-16%